We demonstrated that DSS-induced colitis is more severe in mice that express only STAT3α compared to wild-type mice and that administration of a selective, small-molecule inhibitor of STAT3, TTI-101, completely prevented DSS-induced colitis as well as reversed upregulation of CRC-associated genes. The gene discussed is STAT3; the disease is colorectal carcinoma.